DR. HOLLY HYDE BIRDSALL, M.D., PH.D.
Medical Practice at Holcombe Blvd, Houston, TX
License number
Texas G9326
Category
Medical Practice
Type
Otolaryngology
Address
Address
2002 Holcombe Blvd, Houston, TX 77030
Phone
(713) 794-7775
(713) 664-9537
(713) 664-9537
Professional information
Holly Hyde Birdsall, Houston TX
Specialties:
Ear, Nose & Throat Doctor
Address:
2002 Holcombe Blvd, Houston, TX 77030
1 Baylor Plz, Houston, TX 77030
1 Baylor Plz, Houston, TX 77030
Education:
Baylor University, College of Medicine - Doctor of Medicine
Baylor University, College of Medicine - Doctor of Philosophy
Baylor Clinic & Hospital - Residency - Otolaryngology
Baylor University, College of Medicine - Doctor of Philosophy
Baylor Clinic & Hospital - Residency - Otolaryngology
Board certifications:
American Board of Otolaryngology Certification in Otolaryngology
Dr. Holly H Birdsall, Houston TX - MD (Doctor of Medicine)
Address:
2002 Holcombe Blvd, Houston 77030
(713) 794-7775 (Phone)
Houston Office
1 Baylor Plz, Houston 77030
(713) 798-1600 (Phone), (713) 798-1642 (Fax)
(713) 794-7775 (Phone)
Houston Office
1 Baylor Plz, Houston 77030
(713) 798-1600 (Phone), (713) 798-1642 (Fax)
Hospitals:
2002 Holcombe Blvd, Houston 77030
Houston Office
1 Baylor Plz, Houston 77030
Houston Office
1 Baylor Plz, Houston 77030
Education:
Medical Schools
Baylor University
Graduated: 1984
Baylor University
Graduated: 1984
Use Of Monoclonal Antibodies And Functional Assays For Prediction Of Risk Of Opportunistic Infection
US Patent:
2003007, Apr 24, 2003
Filed:
Mar 20, 2002
Appl. No.:
10/102062
Inventors:
Joann Trial - Houston TX, US
Roger Rossen - Houston TX, US
Holly Birdsall - Houston TX, US
Roger Rossen - Houston TX, US
Holly Birdsall - Houston TX, US
International Classification:
C12Q001/70, G01N033/53, G01N033/537, G01N033/543, C07K016/00, C12P021/08
US Classification:
435/005000, 435/007100, 435/975000, 435/007920, 530/388300
Abstract:
The present invention is drawn to methods of detecting and monitoring a subject at risk for opportunistic infection. More particularly, the methods comprise monitoring key monocyte functions and surrogate cell surface markers on monocytes to predict subjects at risk for opportunistic infection. Specific monocyte key functions comprise measurements of phagocytic activity and transendothelial migration. Another aspect of the present invention is a kit comprising the compositions of the present invention used to detect or monitor a subject at risk for opportunistic infection.